1. Home
  2. ARGX vs FANG Comparison

ARGX vs FANG Comparison

Compare ARGX & FANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARGX
  • FANG
  • Stock Information
  • Founded
  • ARGX 2008
  • FANG 2007
  • Country
  • ARGX Netherlands
  • FANG United States
  • Employees
  • ARGX N/A
  • FANG N/A
  • Industry
  • ARGX Biotechnology: Biological Products (No Diagnostic Substances)
  • FANG Oil & Gas Production
  • Sector
  • ARGX Health Care
  • FANG Energy
  • Exchange
  • ARGX Nasdaq
  • FANG Nasdaq
  • Market Cap
  • ARGX 40.4B
  • FANG 38.9B
  • IPO Year
  • ARGX 2017
  • FANG 2012
  • Fundamental
  • Price
  • ARGX $549.65
  • FANG $137.89
  • Analyst Decision
  • ARGX Strong Buy
  • FANG Strong Buy
  • Analyst Count
  • ARGX 20
  • FANG 21
  • Target Price
  • ARGX $698.22
  • FANG $197.86
  • AVG Volume (30 Days)
  • ARGX 423.4K
  • FANG 2.3M
  • Earning Date
  • ARGX 05-08-2025
  • FANG 05-05-2025
  • Dividend Yield
  • ARGX N/A
  • FANG 3.80%
  • EPS Growth
  • ARGX N/A
  • FANG N/A
  • EPS
  • ARGX 15.94
  • FANG 16.37
  • Revenue
  • ARGX $2,643,062,000.00
  • FANG $12,286,000,000.00
  • Revenue This Year
  • ARGX $60.97
  • FANG $39.37
  • Revenue Next Year
  • ARGX $31.50
  • FANG N/A
  • P/E Ratio
  • ARGX $32.07
  • FANG $8.42
  • Revenue Growth
  • ARGX 82.13
  • FANG 46.77
  • 52 Week Low
  • ARGX $352.77
  • FANG $114.00
  • 52 Week High
  • ARGX $678.21
  • FANG $214.50
  • Technical
  • Relative Strength Index (RSI)
  • ARGX 36.21
  • FANG 51.00
  • Support Level
  • ARGX $529.11
  • FANG $127.75
  • Resistance Level
  • ARGX $658.93
  • FANG $137.00
  • Average True Range (ATR)
  • ARGX 17.55
  • FANG 4.02
  • MACD
  • ARGX -6.04
  • FANG 0.92
  • Stochastic Oscillator
  • ARGX 15.82
  • FANG 82.78

About ARGX argenx SE

Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.

About FANG Diamondback Energy Inc.

Diamondback Energy is an independent oil and gas producer in the United States. The company operates exclusively in the Permian Basin. At the end of 2024, the company reported net proven reserves of 3.6 billion barrels of oil equivalent. Net production averaged about 598,000 barrels per day in 2024, at a ratio of 56% oil, 23% natural gas liquids, and 21% natural gas.

Share on Social Networks: